{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:15:37Z","timestamp":1783966537504,"version":"3.55.0"},"reference-count":52,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2019,7,31]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>&lt;P&gt;Background: Rheumatoid Arthritis (RA) is a common inflammatory disease of the\njoints. Due to the importance of inflammation and oxidative stress in the pathogenesis of RA, drugs\nthat have anti-oxidant and anti-inflammatory properties, such as N-acetyl Cysteine (NAC), can be\nused as adjunctive therapy in patients with RA.\n&lt;\/P&gt;&lt;P&gt;\nAims: The aim of this study was to evaluate the effects of oral NAC on inflammatory cytokines and\noxidative stress in patients with RA.\n&lt;\/P&gt;&lt;P&gt;\nMethods: Adjunct to standard treatment, the NAC group (23 patients) received 600 mg of NAC\ntwice daily and the placebo group (19 patients) received identical placebo twice daily for 12 weeks.\nSerum levels of Total Oxidant Status (TOS), Total Antioxidant Capacity (TAC), nitric oxide (NO),\nTotal Thiol Groups (TTG), Malondialdehyde (MDA), tumor necrosis factor-alpha (TNF-&amp;#945;), interleukin-\n6 (IL-6), C-reactive Protein (CRP), and Erythrocyte Sedimentation Rate (ESR) were\nmeasured at baseline and at the end of the study.\n&lt;\/P&gt;&lt;P&gt;\nResults: Results showed that in the NAC group, the serum levels of MDA, NO, IL-6, TNF-&amp;#945;, ESR\nand CRP were significantly lower than the baseline. Also, the serum level of TAC and TTG, as\nantioxidant parameters, increased significantly. However, only NO, MDA and TTG showed a significant\ndifference in the NAC group as compared to the placebo group at the end of study.\n&lt;\/P&gt;&lt;P&gt;\nConclusion: According to the results of this study, oral NAC can significantly reduce the several\noxidative stress factors and inflammatory cytokines. These results need to be confirmed in larger\nstudies while considering clinical outcomes of RA patients.&lt;\/P&gt;<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573403x14666180926100811","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T08:00:25Z","timestamp":1537948825000},"page":"246-253","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["A Pilot Study to Evaluate the Effects of Oral N-Acetyl Cysteine on Inflammatory and Oxidative Stress Biomarkers in Rheumatoid Arthritis"],"prefix":"10.2174","volume":"15","author":[{"given":"Ghazal","family":"Hashemi","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtabalsadat","family":"Mirjalili","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Basiri","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Tahamoli-Roudsari","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nejat","family":"Kheiripour","sequence":"additional","affiliation":[{"name":"Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shahdoust","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Ranjbar","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Pharmacology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mehrpooya","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ataei","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"Diagnosis and differential diagnosis\nof rheumatoid arthritis. UpToDate Post TW ed UpTo-\nDate,Waltham, MA PJW Venables M, MB BChir, MD, FRCPRavinder N Maini, BA, MB BChir, FRCP, FMedSci, FRS.(Accessed on February 23, 2018)","journal-title":"UpToDate Post TW ed UpTo-\nDate,Waltham, MA"},{"key":"ref=2","first-page":"110","volume":"2","author":"Shokri A.","year":"2014","unstructured":"Shokri A.; Yarmohammadian M.H.; Mottaghi P.; Karimi S.; Customer Quality and Rheumatoid Arthritis in the Iranian Patient\u2019s Perspective: A Cross-Sectional Study. Journal of Patient Safety  2014,2(3),110-115","journal-title":"Journal of Patient Safety"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/1756-185X.12809","volume":"19","author":"Davatchi F","year":"2016","unstructured":"Davatchi F; Sandoughi M; Moghimi N; Epidemiology of\nrheumatic diseases in Iran from analysis of four COPCORD studies Int J Rheum Dis 2016,19(11),1056-62","journal-title":"Int J Rheum Dis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3899\/jrheum.101133","volume":"38","author":"Myasoedova E","year":"2011","unstructured":"Myasoedova E; Crowson CS; Turesson C; Gabriel SE; Matteson EL; Incidence of extraarticular rheumatoid arthritis in Olmsted\nCounty, Minnesota, in 1995-2007 versus 1985-1994: a populationbased\nstudy. J Rheumatol 2011,38(6),983-9","journal-title":"J Rheumatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"McInnes IB","year":"2011","unstructured":"McInnes IB; Schett G; The pathogenesis of rheumatoid arthritis N Engl J Med 2011,365(23),2205-19","journal-title":"N Engl J Med"},{"key":"ref=6","volume":"21","author":"Wei S-T","year":"2015","unstructured":"Wei S-T; Sun Y-H; Zong S-H; Xiang Y-B; Serum levels of IL-6 and TNF-\u03b1 may correlate with activity and severity of rheumatoid\narthritis. Med Sci Monit: international medical journal of experimental\n   and clinical research 2015,21(4030)","journal-title":"Med Sci Monit: international medical journal of experimental\n   and clinical research"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1136\/annrheumdis-2014-205635","volume":"75","author":"Angiolilli C","year":"2016","unstructured":"Angiolilli C; Grabiec AM; Ferguson BS; Inflammatory cytokines\nepigenetically regulate rheumatoid arthritis fibroblast-like\nsynoviocyte activation by suppressing HDAC5 expression. Ann Rheum Dis 2016,75(2),430-8","journal-title":"Ann Rheum Dis"},{"key":"ref=8","author":"Niu X","year":"2014","unstructured":"Niu X; Chen G; Clinical biomarkers and pathogenic-related cytokines\nin rheumatoid arthritis.  J Immunol Res 2014 2014","journal-title":"J Immunol Res 2014"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s002960050097","volume":"19","author":"Ozt\u00fcrk HS","year":"1999","unstructured":"Ozt\u00fcrk HS; Cimen MY; Cimen OB; Ka\u00e7maz M; Durak I; Oxidant\/\nantioxidant status of plasma samples from patients with rheumatoid\narthritis. Rheumatol Int 1999,19(1-2),35-7","journal-title":"Rheumatol Int"},{"key":"ref=10","first-page":"16","volume":"10","author":"Preedy V.","year":"1998","unstructured":"Preedy V.; Reilly M.; Mantle D.; Peters T.; Oxidative damage in liver disease. J Int Fed Clin Chem 1998,10,16-20","journal-title":"J Int Fed Clin Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-0348-9074-8_7","author":"Pincemail J.","year":"1995","unstructured":"Pincemail J.;  Free radicals and antioxidants in human diseases Analysis of free radicals in biological systems 1995,83-98","journal-title":"Free radicals and antioxidants in human diseases Analysis of free radicals in biological systems"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/1043-4666(91)90015-6","volume":"3","author":"Ghezzi P","year":"1991","unstructured":"Ghezzi P; Dinarello CA; Bianchi M; Rosandich ME; Repine JE; White CW;  Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells Cytokine 1991,3(3),189-94","journal-title":"Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells Cytokine"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/art.23721","volume":"59","author":"Saag KG","year":"2008","unstructured":"Saag KG; Teng GG; Patkar NM;  American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis Arthritis Rheum 2008,59(6),762-84","journal-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis Arthritis Rheum"},{"key":"ref=14","year":"2000","unstructured":"Natural Therapies for Rheumatoid Arthritis and Other Chronic Inflammatory Conditions SUTTER FT2000","journal-title":"Natural Therapies for Rheumatoid Arthritis and Other Chronic Inflammatory Conditions"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3349\/ymj.2004.45.5.776","volume":"45","author":"Atmaca G.","year":"2004","unstructured":"Atmaca G.; Antioxidant effects of sulfur-containing amino acids. Yonsei Med J 2004,45(5),776-788","journal-title":"Yonsei Med J"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1503\/jpn.100057","volume":"36","author":"Dean O.","year":"2011","unstructured":"Dean O.; Giorlando F.; Berk M.; N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci 2011,36(2),78-86","journal-title":"J Psychiatry Neurosci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1183\/09031936.04.00016804","volume":"23","author":"Dekhuijzen P.N.","year":"2004","unstructured":"Dekhuijzen P.N.; Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur Respir J 2004,23(4),629-636","journal-title":"Eur Respir J"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1056\/NEJM200007203430304","volume":"343","author":"Tepel M.","year":"2000","unstructured":"Tepel M.; van der Giet M.; Schwarzfeld C.; Laufer U.; Liermann D.; Zidek W.; Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000,343(3),180-184","journal-title":"N Engl J Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0735-1097(02)01797-7","volume":"39","author":"Sochman J.","year":"2002","unstructured":"Sochman J.; N-acetylcysteine in acute cardiology: 10 years later: what do we know and what would we like to know?! J Am Coll Cardiol 2002,39(9),1422-1428","journal-title":"J Am Coll Cardiol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","volume":"7","author":"Atkuri K.R.","year":"2007","unstructured":"Atkuri K.R.; Mantovani J.J.; Herzenberg L.A.; Herzenberg L.A.; N-Acetylcysteine--a safe antidote for cysteine\/glutathione deficiency. Curr Opin Pharmacol 2007,7(4),355-359","journal-title":"Curr Opin Pharmacol"},{"key":"ref=21","author":"Kim H.R.","year":"2017","unstructured":"Kim H.R.; Kim K.W.; Kim B.M.; Lee K.A.; Lee S.H.; N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL in rheumatoid arthritis. Korean J Intern Med (Korean Assoc Intern Med) 2017","journal-title":"Korean J Intern Med (Korean Assoc Intern Med)"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"Aletaha D.","year":"2010","unstructured":"Aletaha D.; Neogi T.; Silman A.J.; 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010,62(9),2569-2581","journal-title":"Arthritis Rheum"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/ar1820","volume":"7","author":"van Riel P.L.","year":"2005","unstructured":"van Riel P.L.; Fransen J.; DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis. Arthritis Res Ther 2005,7(5),189-190","journal-title":"Arthritis Res Ther"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1021\/jf9807768","volume":"47","author":"Benzie I.F.","year":"1999","unstructured":"Benzie I.F.; Szeto Y.T.; Total antioxidant capacity of teas by the ferric reducing\/antioxidant power assay. J Agric Food Chem 1999,47(2),633-636","journal-title":"J Agric Food Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.clinbiochem.2005.08.008","volume":"38","author":"Erel O.","year":"2005","unstructured":"Erel O.; A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005,38(12),1103-1111","journal-title":"Clin Biochem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"Ohkawa H.","year":"1979","unstructured":"Ohkawa H.; Ohishi N.; Yagi K.; Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979,95(2),351-358","journal-title":"Anal Biochem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"Ellman G.L.","year":"1959","unstructured":"Ellman G.L.; Tissue sulfhydryl groups. Arch Biochem Biophys 1959,82(1),70-77","journal-title":"Arch Biochem Biophys"},{"key":"ref=28","first-page":"343","volume":"64","author":"Westergren A.","year":"1926","unstructured":"Westergren A.; On the Clinical Import of the Red Cell Sedimentation Reaction in Diseases of the Joints. J Intern Med 1926,64(S16),343-354","journal-title":"J Intern Med"},{"key":"ref=29","first-page":"140","volume":"44","author":"Purwanto B.","year":"2012","unstructured":"Purwanto B.; Prasetyo D.H.; Effect of oral N-acetylcysteine treatment on immune system in continuous ambulatory peritoneal dialysis patients. Acta Med Indones 2012,44(2),140-144","journal-title":"Acta Med Indones"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","volume":"14","author":"Feldmann M.","year":"1996","unstructured":"Feldmann M.; Brennan F.M.; Maini R.N.; Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996,14,397-440","journal-title":"Annu Rev Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/07853899709007474","volume":"29","author":"Isom\u00e4ki P.","year":"1997","unstructured":"Isom\u00e4ki P.; Punnonen J.; Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med 1997,29(6),499-507","journal-title":"Ann Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/978-1-4615-0171-8_11","author":"Lubberts E.","year":"2003","unstructured":"Lubberts E.; Berg W.B.;  Cytokines in the pathogenesis of rheumatoid arthritis and collagen-induced arthritis 2003,194-202","journal-title":"Cytokines in the pathogenesis of rheumatoid arthritis and collagen-induced arthritis"},{"key":"ref=33","first-page":"7","volume":"45","author":"Hadjigogos K.","year":"2003","unstructured":"Hadjigogos K.; The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med 2003,45(1),7-13","journal-title":"Panminerva Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1756-185X.2011.01630.x","volume":"14","author":"Hassan S.Z.","year":"2011","unstructured":"Hassan S.Z.; Gheita T.A.; Kenawy S.A.; Fahim A.T.; El-Sorougy I.M.; Abdou M.S.; Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis 2011,14(4),325-331","journal-title":"Int J Rheum Dis"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40064-016-1671-1","volume":"5","author":"Bracht A.","year":"2016","unstructured":"Bracht A.; Silveira S.S.; Castro-Ghizoni C.V.; Oxidative changes in the blood and serum albumin differentiate rats with monoarthritis and polyarthritis. Springerplus 2016,5,36","journal-title":"Springerplus"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cccn.2003.08.011","volume":"338","author":"Jaswal S.","year":"2003","unstructured":"Jaswal S.; Mehta H.C.; Sood A.K.; Kaur J.; Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 2003,338(1-2),123-129","journal-title":"Clin Chim Acta"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.arcmed.2015.08.006","volume":"46","author":"Abdollahzad H.","year":"2015","unstructured":"Abdollahzad H.; Aghdashi M.A.; Asghari Jafarabadi M.; Alipour B.; Effects of coenzyme Q10 supplementation on inflammatory cytokines (TNF-\u03b1, IL-6) and oxidative stress in rheumatoid arthritis patients: a randomized controlled trial. Arch Med Res 2015,46(7),527-533","journal-title":"Arch Med Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/ejcn.2010.107","volume":"64","author":"Huang S.C.","year":"2010","unstructured":"Huang S.C.; Wei J.C.; Wu D.J.; Huang Y.C.; Vitamin B(6) supplementation improves pro-inflammatory responses in patients with rheumatoid arthritis. Eur J Clin Nutr 2010,64(9),1007-1013","journal-title":"Eur J Clin Nutr"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"E325","DOI":"10.3390\/nu9040325","volume":"9","author":"Veselinovic M.","year":"2017","unstructured":"Veselinovic M.; Vasiljevic D.; Vucic V.; Clinical Benefits of n-3 PUFA and \u0264-Linolenic Acid in Patients with Rheumatoid Arthritis. Nutrients 2017,9(4),E325","journal-title":"Nutrients"},{"key":"ref=40","first-page":"265","volume":"80","author":"Millea P.J.","year":"2009","unstructured":"Millea P.J.; N-acetylcysteine: multiple clinical applications. Am Fam Physician 2009,80(3),265-269","journal-title":"Am Fam Physician"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0300-483X(98)00074-2","volume":"128","author":"G\u00fcrer H.","year":"1998","unstructured":"G\u00fcrer H.; Ozg\u00fcnes H.; Neal R.; Spitz D.R.; Er\u00e7al N.; Antioxidant effects of N-acetylcysteine and succimer in red blood cells from lead-exposed rats. Toxicology 1998,128(3),181-189","journal-title":"Toxicology"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00109-004-0555-y","volume":"82","author":"Kumar A.","year":"2004","unstructured":"Kumar A.; Takada Y.; Boriek A.M.; Aggarwal B.B.; Nuclear factor-kappaB: its role in health and disease. J Mol Med (Berl) 2004,82(7),434-448","journal-title":"J Mol Med (Berl)"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1167\/iovs.15-16909","volume":"56","author":"Park J.H.","year":"2015","unstructured":"Park J.H.; Kang S-S.; Kim J.Y.; Tchah H.; The antioxidant N-acetylcysteine inhibits inflammatory and apoptotic processes in human conjunctival epithelial cells in a high-glucose environment. Invest Ophthalmol Vis Sci 2015,56(9),5614-5621","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"H1728","DOI":"10.1152\/ajpheart.01328.2005","volume":"292","author":"Guo Z.","year":"2007","unstructured":"Guo Z.; Xia Z.; Jiang J.; McNeill J.H.; Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine. Am J Physiol Heart Circ Physiol 2007,292(4),H1728-H1736","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=45","author":"Lee K-A.","year":"2016","unstructured":"Lee K-A.; Kim H-R.; Lee S.H.; Kim B.; Kim K-W.; NAcetylcysteine\nRegulates Osteoclastogenesis and Th17 Cell Differentiation\nin Rheumatoid ArthritisArthritis"},{"key":"ref=46","first-page":"363","volume":"4","author":"Jonsson H.","year":"1986","unstructured":"Jonsson H.; Wollheim F.A.; Svensson B.; No effect of acetylcystein on refractory rheumatoid arthritis. Clin Exp Rheumatol 1986,4(4),363-364","journal-title":"Clin Exp Rheumatol"},{"key":"ref=47","author":"Remans P","unstructured":"Remans P; Zuijderduin W; Levahrt N; Schuitemaker J; Tak P; Breedveld F; High dose intravenous N-acetyl-L-cysteine\n(NAC) therapy in rheumatoid arthritis, results from a pilot study.\nRole Of Reactive Oxygen Species In Rheumatoid Arthritis Synovial\nT Lymphocytes97"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/1574887113666180307151937","volume":"13","author":"Batooei M.","year":"2018","unstructured":"Batooei M.; Tahamoli-Roudsari A.; Basiri Z.; Evaluating the effect of oral N-acetylcysteine as an adjuvant treatment on clinical outcomes of patients with rheumatoid arthritis: a randomized, double blind clinical trial. Rev Recent Clin Trials 2018,13(2),132-138","journal-title":"Rev Recent Clin Trials"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3747\/pdi.2009.00073","volume":"30","author":"Nascimento M.M.","year":"2010","unstructured":"Nascimento M.M.; Suliman M.E.; Silva M.; Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study. Perit Dial Int 2010,30(3),336-342","journal-title":"Perit Dial Int"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.burns.2011.09.011","volume":"38","author":"Csontos C.","year":"2012","unstructured":"Csontos C.; Rezman B.; Foldi V.; Effect of N-acetylcysteine treatment on oxidative stress and inflammation after severe burn. Burns 2012,38(3),428-437","journal-title":"Burns"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0022-5223(03)00968-1","volume":"126","author":"Tossios P.","year":"2003","unstructured":"Tossios P.; Bloch W.; Huebner A.; N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 2003,126(5),1513-1520","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref=52","first-page":"454","volume":"9","author":"Allameh Z.","year":"2015","unstructured":"Allameh Z.; Karimi A.; Rafiei Tabatabaei S.; Sharifian M.; Salamzadeh J.; Effect of N-acetylcysteine on inflammation biomarkers in pediatric acute pyelonephritis: a randomized controlled trial. Iran J Kidney Dis 2015,9(6),454-462","journal-title":"Iran J Kidney Dis"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/165674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T15:52:08Z","timestamp":1567957928000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/165674\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7,31]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573403x14666180926100811","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,31]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}